The Registry Office does not review or approve the safety and science of the studies listed on this website.
Read our full disclaimer for details.
Cardiac rehabilitation via mobile app after myocardial infarction
- BDCTR ID
- BDCTR-2026-000042
- Sponsor
- Bangladesh Medical University
- Information provided by
- Bangladesh Medical University (Responsible Party)
- Last Update Posted
- 2026-10-14
Status not given
No longer looking for participants
Trial Contacts
| ContactsICMJE | Contact information is displayed when a study is open for participants to join. |
|---|
Study Record Dates
| First SubmittedICMJE | 2026-10-14 |
|---|---|
| First PostedICMJE | 2026-09-20 |
| Last Update Posted | 2026-10-14 |
| Last Verified* | Not provided |
Outcome Measures
| Primary Outcome Measures*ICMJE | Change in peak VO2 at 12 weeks [Time Frame: 6 months] |
|---|---|
| Secondary Outcome Measures[*]ICMJE | Adverse events [Time Frame: 6 months] |
| Other Pre-specified Outcome Measures | Not provided |
Trial Description
| Brief Title*ICMJE | Cardiac rehabilitation via mobile app after myocardial infarction |
|---|---|
| Official Title*§ICMJE | A randomized controlled trial of app-delivered cardiac rehabilitation after acute myocardial infarction |
| Acronym[*] | Not provided |
| Brief Summary* | Not provided |
| Detailed Description | Not provided |
| Study Type*ICMJE | Interventional |
| Study Phase*ICMJE | N/A |
| Study Design*§ICMJE | Allocation: Randomized Masking: Double blind Primary Purpose: Treatment |
| Condition*ICMJE | Myocardial infarction |
| Keywords | Not provided |
| Intervention*ICMJE | Device: Mobile cardiac rehabilitation app |
| Study Arms*ICMJE | Not provided |
| Publications | Not provided |
Recruitment Information
| Recruitment Status*ICMJE | |
|---|---|
| Enrollment*§ICMJE | 300 |
| Study Start Date*§ICMJE | 2026-03-01 |
| Primary Completion Date* | Not provided |
| Study Completion Date*§ICMJE | 2027-03-01 |
| Eligibility Criteria*ICMJE | Inclusion Criteria: Adults aged 18–65 meeting the diagnostic criteria, able to give informed consent. Exclusion Criteria: Pregnancy, severe comorbidity, or inability to attend follow-up. |
| Sex/Gender*ICMJE | Sexes Eligible for Study: All |
| Ages*ICMJE | All ages (Child, Adult, Older Adult) |
| Accepts Healthy Volunteers*§ICMJE | Not provided |
| Location CountriesICMJE | Not provided |
Administrative Information
| BDCTR NumberICMJE | BDCTR-2026-000042 |
|---|---|
| Other Study ID Numbers[*]ICMJE | DRAFT-2026-000090 |
| Has Data Monitoring Committee | Not provided |
| Studies a U.S. FDA-regulated Drug Product | Not provided |
| Studies a U.S. FDA-regulated Device Product | Not provided |
| Device Product Not Approved or Cleared by U.S. FDA | Not provided |
| Pediatric Postmarket Surveillance of a Device Product | Not provided |
| Product Manufactured in and Exported from the U.S. | Not provided |
| IPD Sharing StatementICMJE | Plan to Share IPD: Not provided |
| Current Responsible Party* | Bangladesh Medical University |
| Current Study Sponsor*ICMJE | Bangladesh Medical University |
| CollaboratorsICMJE | Not provided |
| InvestigatorsICMJE | Not provided |
| Registry Account | Bangladesh Medical University |
Symbol Legend
- *
- Required
- *§
- Required if Study Start Date is on or after January 18, 2017 — required for every BMU study
- [*]
- Conditionally required
- No Symbol
- Unmarked fields are optional. If no information is provided, fields will be labeled as “Not provided”.
- ICMJE
- Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP